Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review-Reference-Cited by-同舟云学术

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review

Published:2022-08-27 Issue:8 Volume:10 Page:854-867
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:UEG Journal

Author:

Caron Bénédicte¹,Jairath Vipul²³⁴,D’Amico Ferdinando⁵⁶^ORCID,Paridaens Kristine⁷,Magro Fernando⁸⁹¹⁰^ORCID,Danese Silvio⁵,Peyrin‐Biroulet Laurent¹^ORCID

Affiliation:

1. Department of Gastroenterology and Inserm NGERE U1256 Nancy University Hospital University of Lorraine Nancy France

2. Department of Medicine Western University London Ontario Canada

3. Department of Epidemiology and Biostatistics Western University London Ontario Canada

4. Alimentiv Inc London Ontario Canada

5. Gastroenterology and Endoscopy IRCCS Ospedale San Raffaele and University Vita‐Salute San Raffaele Milano Milan Italy

6. Department of Biomedical Sciences Humanitas University Milan Italy

7. Ferring International Center Saint‐Prex Switzerland

8. Department of Biomedicine Unit of Pharmacology and Therapeutics Faculty of Medicine University of Porto Porto Portugal

9. Department of Clinical Pharmacology São João University Hospital Center (CHUSJ) Porto Portugal

10. Faculty of Medicine, University of Porto Center for Health Technology and Services Research (CINTESIS) Porto Portugal

Funder

Ferring Pharmaceuticals

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12283

Reference59 articles.

1. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

2. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

3. Current best practice for disease activity assessment in IBD

4. Positioning Therapies in Ulcerative Colitis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of twice‐daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis;Journal of Gastroenterology and Hepatology;2024-08-04

2. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

3. The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis;Frontiers in Gastroenterology;2024-06-03

4. Management and treatment optimization of patients with mild to moderate ulcerative colitis;Expert Review of Clinical Immunology;2023-12-07

5. Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus;Journal of Clinical Medicine;2023-11-04